RESTYLANE Refyne and RESTYLANE Defyne
FDA premarket approval P140029/S016 · decided 2019-03-15
Approval details
- PMA number
- P140029
- Supplement
- S016
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- RESTYLANE Refyne and RESTYLANE Defyne
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2019-02-14
- Decision date
- 2019-03-15
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- Change to the frequency for performing the In-Process Control of the syringe fill weights for Restylane Refyne and Restylane Defyne.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.